Press Release

Attention Deficit Hyperactivity Market to Grow at 8.4% CAGR by 2026

July, 2021

" COVID-19 Impact on Attention Deficit Hyperactivity Market, size, share, growth, industry analysis, and forecast 2020-2026 "

Attention Deficit Hyperactivity Disorder is known as neurodevelopment disorder that is usually diagnosed among children and observed in teenagers and adults. A person with ADHD may be hyperactive and unable to control their desire or have difficulty paying attention. Symptoms of ADHD are a lower attention span or being easily distracted, feel restlessness, continuous fuss or overactivity, and being impulsive.

The rising number of brain injuries or brain disorders due to accidents and mishaps are increasing the incidence of attention deficit hyperactivity disorder which is the key factor responsible for the market's growth. Moreover, the COVID-19 pandemic is surely difficult for people with attention-deficit hyperactivity disorder due to their vulnerability to distress because of the pandemic and physical distancing measures. The consequences for these measures may result in increased behavioral problems in individuals with ADHD. As a result, ADHD therapeutics will witness significant growth in sales. Moreover, the consumer's panic purchasing essentials as a precautionary measure has led to the out-of-stock of essential medicines, thus driving players to adopt a new batch of medicines. This stands true for ADHD therapeutics as well.

Request for sample copy of the report @

Increasing advancements in the medical field, an increase in research and development in neuroscience, and increasing awareness about the mental illness that is considered social stigma among people are creating opportunities for the growth of the market.

Attention Deficit Hyperactivity Market by Drug Type, Demographic, Distribution Channel and Geography – Global Forecast up to 2026

The top companies operating in the market are Eli Lilly & Company, Supernus Pharmaceuticals, Inc., Johnson & Johnson Services Inc, Hisamitsu Pharmaceutical Co., Inc., and Lupin Limited.

North America is the largest contributor to the market due to increasing research & development activities and many established players in the ADHD market.

The report consists of 90 Tables and 60 charts depicting the in-depth market study and the impact analysis of COVID-19. View detailed TOC here.

Access full report summary @

The Attention Deficit Hyperactivity Market is has been segmented on the basis of:              

Attention Deficit Hyperactivity Market based on Drug Type

  • Stimulant
  • Non-stimulant

 Attention Deficit Hyperactivity Market based on Demographic

  • Adult (Aged 18 and above)
  • Children

Attention Deficit Hyperactivity Market based on Distribution Channel

  • Retail Pharmacy
  • Hospital Pharmacy

Attention Deficit Hyperactivity Market based on Geography

  • North America
  • Europe
  • Asia Pacific
  • Rest of the World

Mr. Karthick Subramani

Infoholic Research LLP

Marketing & Communication